Big Pharma's a sitting duck, just like Goliath was—it doesn't actually have any physical assets
Learn all about Big Pharma's Achilles' heel
There’s nothing new under the sun
As I have been writing these newsletters, beginning January 2022, the key messages have coalesced. I’m recycling this newsletter from April 2022 to explain the single key message that maybe we should all be lining up behind—Big Pharma is nothing when we realise it has no physical assets to develop new drugs. It therefore had to revert to fraud to make blockbuster returns for investors, and that can be proven, if lawyers were able to understand the opportunity they have.
The excerpt from the post below explains more:
BIG PHARMA GOLIATH—MEET NOT SO DIDDY DAVID!
SMALL DON’T MEAN POWERLESS? Goliath was a giant, covered from head to toe in armour, tooled up to the teeth. David was diddy (little, for our non-UK friends). He was a lowly shepherd, without a scrap of armour, and only a sling and stone to defend himself.
“WHERE DOES DAVID AND GOLIATH COME IN?
The first message from the analogy is this. Big Pharma is in a bad way.
This self-inflicted addiction to easy money earned in the good-old-days, has left investors really unhappy with any whiff of diminishing returns. With so few new, better drugs getting to market due to the above, desperation has stepped.
Who would have thought the world would need annual, mutiple doses of gene therapy products, administered by injection, for the foreseeable future?
Me neither.”
The Physical Assets that Went
These are the physical assets that went out the boat in the early 1980s: